What Researchers Did
Researchers reported a case where a patient developed a systemic air embolism during general anesthesia after an artificial pneumothorax was created to help diagnose a mediastinal mass.
What They Found
The patient experienced sudden changes in vital signs and neurological problems, suggesting air had reached both the heart and brain. Despite a 10-hour delay between the air embolism and treatment, the patient recovered well after receiving hyperbaric oxygen therapy.
What This Means for Canadian Patients
This case highlights that hyperbaric oxygen therapy (HBOT) can be an effective treatment for systemic air embolism, even when there is a significant delay before treatment begins. For Canadian patients experiencing similar critical events, this suggests that HBOT should be considered as a viable intervention.
Canadian Relevance
This study covers arterial gas embolism, which is a Health Canada-recognized indication for hyperbaric oxygen therapy.
Study Limitations
As a single case report, this study's findings may not apply to all patients experiencing systemic air embolism.